Medical treatment of epithelial ovarian cancer.

about

Anti-tumour activity of phosphoinositide-3-kinase antagonist AEZS-126 in models of ovarian cancer.

P2860

Q38966925-FD948A54-45E5-415F-B101-9CB944663695

P2860

Medical treatment of epithelial ovarian cancer.

Item

http://www.wikidata.org/entity/Q35987782

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

Medical treatment of epithelial ovarian cancer.

@ast

Medical treatment of epithelial ovarian cancer.

@en

type

Item

label

Medical treatment of epithelial ovarian cancer.

@ast

Medical treatment of epithelial ovarian cancer.

@en

prefLabel

Medical treatment of epithelial ovarian cancer.

@ast

Medical treatment of epithelial ovarian cancer.

@en

P1476

Medical treatment of epithelial ovarian cancer.

@en

P2093

Antonio J González-Martín

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2004

Second-line carboplatin and gemcitabine in platinum sensitive ovarian cancer--a dose-finding study by the Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) Ovarian Cancer Study Group.

A phase I/II study of topotecan in combination with carboplatin in recurrent epithelial ovarian cancer.

Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis.

International Collaborative Ovarian Neoplasm trial 1 and Adjuvant ChemoTherapy In Ovarian Neoplasm trial: two parallel randomized phase III trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma.

Systematic review of first-line chemotherapy for newly diagnosed postoperative patients with stage II, III, or IV epithelial ovarian cancer.

The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume stage III epithelial ovarian cancer: a Gynecologic Oncology Group study.

Randomized trial comparing cisplatin with radioactive phosphorus or whole-abdomen irradiation as adjuvant treatment of ovarian cancer.

Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer.

A randomized clinical trial of cisplatin/paclitaxel versus carboplatin/paclitaxel as first-line treatment of ovarian cancer.

P304

1125-1143

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14737140.4.6.1125

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2004-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15606338

http://www.w3.org/2001/XMLSchema#string

P921

ovarian cancer

Medical treatment of epithelial ovarian cancer.

about

P2860

P2860

Medical treatment of epithelial ovarian cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921